Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial
2011

Effect of Oral Vitamin B12 on Subtle Deficiency

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Favrat Bernard, Vaucher Paul, Herzig Lilli, Burnand Bernard, Ali Giuseppa, Boulat Olivier, Bischoff Thomas, Verdon François

Primary Institution: University of Lausanne

Hypothesis

Does oral vitamin B12 supplementation effectively reduce methylmalonic acid levels in patients with borderline vitamin B12 deficiency?

Conclusion

Oral vitamin B12 treatment lowered metabolic markers of vitamin B12 deficiency, but the effects did not last beyond one month after treatment ended.

Supporting Evidence

  • One month of vitamin B12 treatment lowered serum MMA levels by 0.13 μmol/l more than placebo.
  • The number needed to treat to see a metabolic response was 2.6 patients.
  • Significant changes were observed in serum vitamin B12 levels after treatment.

Takeaway

This study tested if taking vitamin B12 pills helps people who might not have enough vitamin B12. It found that the pills worked for a little while, but not for long.

Methodology

A multicentre, parallel, randomised controlled trial with 50 patients receiving either oral vitamin B12 or placebo for four weeks.

Potential Biases

Potential bias due to missing data and the inclusion of non-anaemic patients who may not respond to treatment.

Limitations

Some data were missing due to mishandling of blood samples and non-return of electronic devices measuring treatment compliance.

Participant Demographics

Participants were primarily elderly patients with borderline serum vitamin B12 levels.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 0.06-0.19

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2296-12-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication